The market has been down on Sonoma Pharmaceuticals Inc (SNOA) stock recently. SNOA gets a Bearish score from InvestorsObserver's Stock Sentiment Indicator.
What is Stock Sentiment?
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.
InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.
Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.
What's Happening With SNOA Stock Today?
Sonoma Pharmaceuticals Inc (SNOA) stock is higher by 5.15% while the S&P 500 is down -2.78% as of 10:53 AM on Thursday, Sep 10. SNOA is higher by $0.35 from the previous closing price of $6.79 on volume of 138,590 shares. Over the past year the S&P 500 has risen 11.83% while SNOA is higher by 8.18%. SNOA lost -$1.87 per share in the over the last 12 months.
To see InvestorsObserver's Sentiment Score for Sonoma Pharmaceuticals Inc click here.
More About Sonoma Pharmaceuticals Inc
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing and commercializing differentiated therapies to patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes and others. The company derives revenue from the sale of products in the United States, Latin America, Europe and other countries.
Click Here to get the full Stock Score Report on Sonoma Pharmaceuticals Inc (SNOA) Stock.
